CAS NO: | 1421372-66-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
500mg | 电议 |
1 g | 电议 |
5 g | 电议 |
生物活性 | Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutatedEGFR, such as L858REGFR, Exonl9 deletion activating mutant and T790M resistance mutant. IC50 value: Target: MutatedEGFRinhibitor More information can be found in Patent WO 2013014448 A1.2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives asegfrmodulators useful for treatingcancer. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
分子量 | 445.56 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C25H31N7O | ||||||||||||||||
CAS 号 | 1421372-66-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 75 mg/mL(168.33 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |